New Astellas CEO Expects Future Partnerships, But Limited M&As
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma's new CEO expects his company to increase its profit this year by 20% over that of a year ago, partly by improving its ability to compete globally